Incidence and Prognostic Significance of HER-2 Status Discordance Between Primary Breast Cancer and Paired Recurrent/Metastatic Lesions
Clinical trial NCT05510037 · COMPLETED
Trial details
- NCT number
- NCT05510037
- Sponsor
- Fudan University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-06-01
- Enrollment
- 1299
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.